The invited paper on "transcriptional inhibition in Schwann cell development and nerve regeneration" is a summary of previous and more recent observations on the control of Schwann cell development and on peripheral nerve regeneration. In the latter process Schwann cells have been recognized to be key players and to undergo first de-and then redifferentiation. This review first summarizes factors which have previously been shown to be involved in controlling cellular maturation as well as the generation of the repair mediating phenotype. It then provides a quite detailed compilation of recent findings related to zeb2 and its impact on the redifferentiation process, as opposed to c-jun and its impact on the dedifferentiation process. I would appreciate if in the context of negative regulators of Schwann cell differentiation additional published factors could be mentioned and discussed such SSeCKS, Dlg1, RXR, RAR, cdkn1c, LXR, MLCK, Cthrc1, p38 MAPK, TACE/ADAM17, Hes5, Rac1 GTPase, DDIT4/RTP801/REDD1. The therapeutic aspect is only generally discussed and I wonder whether the authors could comment also on the most promising targets when it comes to a potential modulation from outside. In fact this is another reason not to focus only on transcriptional regulators. Readability would much profit if the text could be better structured and maybe divided in more subchapters.
